Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F17%3A10365397" target="_blank" >RIV/00216208:11160/17:10365397 - isvavai.cz</a>
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S0143400417311657" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0143400417311657</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.placenta.2017.10.011" target="_blank" >10.1016/j.placenta.2017.10.011</a>
Alternative languages
Result language
angličtina
Original language name
Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine
Original language description
Zidovudine (AZT) and emtricitabine (FTC) are effective and well tolerated antiretroviral drugs, routinely used in the prevention of perinatal HIV transmission. However, precise mechanism(s) involved in their transfer from mother to fetus are not fully elucidated. Since both drugs are nucleoside analogues, we hypothesized that the mechanisms of their transplacental passage might include quilibrative nucleoside transporters, ENT1 and/or ENT2. To address this issue, we performed in vitro accumulation assays in the BeWo placental trophoblast cell line, ex vivo uptake studies in fresh villous fragments isolated from human placenta and in situ dually perfused rat term placenta experiments. Applying this complex array of methods, we did not prove that ENTs play a significant role in transfer of AZT or FTC across the placenta. We conclude that the transplacental passage of AZT and FTC is independent of ENTs. Disposition of either compound into the fetal circulation should thus not be affected by ENT-mediated drug-drug interactions or placental expression of the transporters.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
<a href="/en/project/GA17-16169S" target="_blank" >GA17-16169S: In vitro, in situ and ex vivo study of interactions of novel antiviral agents with drug transporters; effect on their passage across the placenta</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Placenta
ISSN
0143-4004
e-ISSN
—
Volume of the periodical
60
Issue of the periodical within the volume
December
Country of publishing house
GB - UNITED KINGDOM
Number of pages
7
Pages from-to
86-92
UT code for WoS article
000417981200012
EID of the result in the Scopus database
2-s2.0-85033443395